<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="0" ids="16247">Phospholipid</z:chebi> transfer protein (PLTP) is an emerging cardiometabolic risk marker that is important in <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> metabolism </plain></SENT>
<SENT sid="1" pm="."><plain>Plasma PLTP activity is elevated in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, whereas <z:chebi fb="105" ids="17234">glucose</z:chebi> may regulate PLTP gene transcription in vitro </plain></SENT>
<SENT sid="2" pm="."><plain>Of interest, common PLTP variations that predict <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> have been identified recently </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated whether the diabetic state is able to amplify relationships between <z:hpo ids='HP_0001513'>obesity</z:hpo> and PLTP gene variations with circulating PLTP levels </plain></SENT>
<SENT sid="4" pm="."><plain>SUBJECTS AND METHODS: Plasma PLTP activity (using a <z:chebi fb="0" ids="16247">phospholipid</z:chebi> vesicles-<z:chebi fb="17" ids="39025">HDL</z:chebi> system), PLTP gene score [number of PLTP activity-decreasing alleles based on two tagging polymorphisms (rs378114 and rs60- 65904)] and waist circumference were determined in two Dutch cohorts comprising 237 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and 78 control subjects </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Patients with <z:mp ids='MP_0002055'>diabetes</z:mp> were more <z:mp ids='MP_0001261'>obese</z:mp> (P &lt; 0.001 for prevalence of increased waist circumference) and had 13% higher plasma PLTP activity (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>PLTP gene score was not different in diabetic and control subjects (P = 0.40) </plain></SENT>
<SENT sid="7" pm="."><plain>PLTP activity was highest in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> with an enlarged waist and lowest in control subjects with a <z:mpath ids='MPATH_458'>normal</z:mpath> waist circumference (P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Multiple linear regression analysis revealed a positive interaction between <z:mp ids='MP_0002055'>diabetes</z:mp> status and waist circumference on PLTP activity (β = 0.200, P = 0.005) </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, <z:mp ids='MP_0002055'>diabetes</z:mp> status (β = -0.485, P = 0.046) or HbA1c (β = -0.240, P = 0.035) interacted with PLTP gene score to affect PLTP activity </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and enlarged waist circumference interact to impact on plasma PLTP activity </plain></SENT>
<SENT sid="11" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> may also amplify the association between plasma PLTP activity and common PLTP gene variations </plain></SENT>
<SENT sid="12" pm="."><plain>Our findings support the hypothesis that <z:mp ids='MP_0002055'>diabetes</z:mp>-environment and <z:mp ids='MP_0002055'>diabetes</z:mp>-gene interactions govern plasma PLTP activity </plain></SENT>
</text></document>